Letters to the Editor

Effectiveness of apremilast against Behçet’s disease-associated mucocutaneous and joint involvement confirmed through switching from adalimumab

N. Azuma¹, K. Matsui²

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan. naoazuuh@hyo-med.ac.jp
Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.

CER15515
2022 Vol.40, N°8
PI 1605, PF 1606
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 36106543 [PubMed]

Received: 22/01/2022
Accepted : 16/06/2022
In Press: 15/09/2022
Published: 15/09/2022